Abstract
This Frost & Sullivan research service titled European Bladder Cancer
Therapeutics Markets presents a concise analysis of the market that includes
challenges, factors driving growth and the revenue forecasts from 2003 to
2013. The study identifies the competitive opportunities within the market as
well as strategies to exploit these opportunities and overcome industry
challenges. In this research, Frost & Sullivan' s expert analysts thoroughly
examine the cytotoxic (chemotherapy therapies) and targeted therapies segments.
This analysis is available through our Pharmaceuticals & Biotechnology Growth
Partnership Services programme. With this programme, clients receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils.
View Cart
